Measuring Signal Detection Performance: Can We Trust Negative Controls and Do We Need Them?

Overview

Journal Drug Saf

Specialties Pharmacology
Toxicology

Date 2016 Feb 20

PMID 26895343

Citations 3

Authors

Jim Slattery

Affiliations

Soon will be listed here.

Citing Articles

Detecting early safety signals of infliximab using machine learning algorithms in the Korea adverse event reporting system.

Lee J, Kim J, Bae J, Song I, Shin J Sci Rep. 2022; 12(1):14869.

PMID: 36050484 PMC: 9436954. DOI: 10.1038/s41598-022-18522-z.

The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions.

Candore G, Monzon S, Slattery J, Piccolo L, Postigo R, Xurz X Drug Saf. 2021; 45(1):83-95.

PMID: 34881404 PMC: 8763735. DOI: 10.1007/s40264-021-01137-0.

On Designs for Vaccine Surveillance.

Platt R Drug Saf. 2016; 39(12):1161-1162.

PMID: 27785767 DOI: 10.1007/s40264-016-0457-2.

References

Ryan P, Schuemie M, Welebob E, Duke J, Valentine S, Hartzema A . Defining a reference set to support methodological research in drug safety. Drug Saf. 2013; 36 Suppl 1:S33-47. DOI: 10.1007/s40264-013-0097-8. View

Hauben M, Aronson J, Ferner R . Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP). Drug Saf. 2016; 39(5):421-32. DOI: 10.1007/s40264-016-0392-2. View